Your session is about to expire
← Back to Search
Antibiotic
Minocycline for Stroke
Phase 2
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age of 18 to 85 years
Diagnosis of ruptured cerebral aneurysm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured baseline at time of enrollment and every other day until 14 days
Awards & highlights
Study Summary
This trialaims to determine if MMP9 levels can predict vasospasm in aneurysm patients, and investigate minocycline as a possible treatment to improve outcomes and reduce hospital stays.
Who is the study for?
This trial is for adults aged 18 to 85 who have had a ruptured cerebral aneurysm and can start the trial within 24 hours of the rupture. It's not suitable for those allergic to tetracycline, pregnant individuals, or people with liver or kidney failure.Check my eligibility
What is being tested?
The MASH trial is testing whether minocycline, which inhibits MMP9 (a molecule involved in brain damage after bleeding), can predict and reduce complications from blood vessel spasms after a brain hemorrhage due to aneurysm rupture.See study design
What are the potential side effects?
Minocycline may cause side effects like dizziness, fatigue, gastrointestinal issues, skin reactions, and possibly affect liver enzymes. The severity of these side effects varies among individuals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 85 years old.
Select...
I have had a ruptured brain aneurysm.
Select...
I was enrolled in the study within a day of my rupture.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured baseline at time of enrollment and every other day until 14 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured baseline at time of enrollment and every other day until 14 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood brain barrier permeability
Secondary outcome measures
Onset of cerebral vasospasm
Serum MMP9 levels
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
899 Previous Clinical Trials
1,595,293 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have kidney failure.I am between 18 and 85 years old.I have had a ruptured brain aneurysm.My liver is not working properly.I was enrolled in the study within a day of my rupture.You are allergic to tetracycline.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger